GNPX
Price
$2.02
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
REVB
Price
$0.85
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

GNPX vs REVB

Header iconGNPX vs REVB Comparison
Open Charts GNPX vs REVBBanner chart's image
Genprex
Price$2.02
Change-$0.00 (-0.00%)
Volume$964.34K
CapitalizationN/A
Revelation Biosciences
Price$0.85
Change-$0.00 (-0.00%)
Volume$12.81K
CapitalizationN/A
View a ticker or compare two or three
GNPX vs REVB Comparison Chart
Loading...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GNPX vs. REVB commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a StrongBuy and REVB is a Sell.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (GNPX: $2.02 vs. REVB: $0.85)
Brand notoriety: GNPX and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 7% vs. REVB: 8%
Market capitalization -- GNPX: $4.69M vs. REVB: $3.29M
GNPX [@Biotechnology] is valued at $4.69M. REVB’s [@Biotechnology] market capitalization is $3.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 1 FA rating(s) are green whileREVB’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 1 green, 4 red.
  • REVB’s FA Score: 1 green, 4 red.
According to our system of comparison, REVB is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 4 TA indicator(s) are bullish while REVB’s TA Score has 3 bullish TA indicator(s).

  • GNPX’s TA Score: 4 bullish, 4 bearish.
  • REVB’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than REVB.

Price Growth

GNPX (@Biotechnology) experienced а -26.28% price change this week, while REVB (@Biotechnology) price change was +2.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

GNPX is expected to report earnings on May 29, 2024.

REVB is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNPX($4.69M) has a higher market cap than REVB($3.29M). GNPX YTD gains are higher at: -78.043 vs. REVB (-94.357). REVB has higher annual earnings (EBITDA): -9.5M vs. GNPX (-26.28M). REVB has more cash in the bank: 12.1M vs. GNPX (2.46M). REVB has less debt than GNPX: REVB (0) vs GNPX (279K). GNPX (0) and REVB (0) have equivalent revenues.
GNPXREVBGNPX / REVB
Capitalization4.69M3.29M142%
EBITDA-26.28M-9.5M277%
Gain YTD-78.043-94.35783%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.46M12.1M20%
Total Debt279K0-
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXREVB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
43%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
37%
View a ticker or compare two or three
Ad is loading...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBWI31.282.36
+8.16%
Bath & Body Works
NNDM2.210.03
+1.61%
Nano Dimension Ltd
MVO8.850.03
+0.34%
MV Oil Trust
BNRG0.84-0.02
-2.33%
Brenmiller Energy Ltd
SRRK27.67-0.75
-2.64%
Scholar Rock Holding Corp

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-6.05%
REVB - GNPX
48%
Loosely correlated
+3.25%
HOWL - GNPX
37%
Loosely correlated
-8.67%
ALLK - GNPX
34%
Loosely correlated
-1.57%
GRI - GNPX
34%
Loosely correlated
-5.45%
ENSC - GNPX
33%
Poorly correlated
-12.60%
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+3.25%
GNPX - REVB
48%
Loosely correlated
-6.05%
TCRT - REVB
46%
Loosely correlated
-1.50%
TOVX - REVB
31%
Poorly correlated
+4.02%
TSHA - REVB
31%
Poorly correlated
-12.42%
CVKD - REVB
28%
Poorly correlated
-18.86%
More